Search Within

Gilles Andre Salles

Formats
  1. Meeting Abstract (181)
  2. Journal Article (74)
  3. Research Letter (18)
  4. Review (17)
  5. Editorial (5)
  6. Correspondence (3)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Book Section (1)
Groups
  1. Department of Medicine (303)
  2. Hematologic Malignancies, Division of (303)
  3. Center for Hematologic Malignancies (163)
  4. Lymphoma (159)
  5. Survivorship Research (115)
  6. Graduate Medical Education (106)

More Groups

People
  1. Maria Palomba (108)
  2. Andrew Zelenetz (74)
  3. Lorenzo Falchi (64)
  4. Anita Kumar (63)
  5. Gunjan Shah (61)
  6. Miguel-Angel Perales (59)

More People

Years
  1. 2025 (20)
  2. 2024 (67)
  3. 2023 (97)
  4. 2022 (69)
  5. 2021 (44)
  6. 2020 (6)
Publications
  1. Blood (126)
  2. Hematological Oncology (28)
  3. Journal of Clinical Oncology (17)
  4. Blood Advances (16)
  5. Haematologica (14)
  6. British Journal of Haematology (9)

More Publications

Publishers
  1. American Society of Hematology (143)
  2. Wiley Blackwell (30)
  3. Elsevier Inc. (20)
  4. American Society of Clinical Oncology (17)
  5. Ferrata Storti Foundation (14)
  6. Nature Publishing Group (14)

More Publishers

Results (303)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic and microenvironment features do not distinguish follicular lymphoma patients requiring immediate or deferred treatment
    Research Letter

    Stevens, W. B. C.; Los-de Vries, G. T.; Langois-Jacques, C.; Clear, A. J.; Stathi, P.; Sander, B.; Rosenwald, A.; Calaminici, M.; Hoster, E.; Hiddemann, W.; more...
    HemaSphere (2023)

    Fulltext@MSK | Save
  • Outcomes of patients with positive interim positron emission tomography (PET) continuing ABVD in the clinical setting
    Journal Article

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S.; Kumar, A.; Matasar, M. J.; more...
    Cancers (2023)

    Fulltext@MSK | Save
  • Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with CREBBP or EP300 mutations: An open label phase II study
    Research Letter

    Qualls, D.; Noy, A.; Straus, D.; Matasar, M.; Moskowitz, C.; Seshan, V.; Dogan, A.; Salles, G.; Younes, A.; Zelenetz, A. D.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1
    Journal Article

    Delage, L.; Lambert, M.; Bardel, É; Kundlacz, C.; Chartoire, D.; Conchon, A.; Peugnet, A. L.; Gorka, L.; Auberger, P.; Jacquel, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clonal hematopoiesis in diffuse large B-cell lymphoma: Clinical impact and genetic relatedness to lymphoma and therapy-related myeloid neoplasm
    Research Letter

    Liu, Y.; Derkach, A.; Lewis, N.; Zhu, M.; Zhang, Y.; Arcila, M.; Salles, G.; Dogan, A.; Xiao, W.
    Haematologica (2023)

    Fulltext@MSK | Save
  • Positron emission tomography-computed tomography before autologous stem cell transplant in follicular lymphoma: Coming too late?
    Editorial

    Sarkozy, C.; Salles, G.
    Haematologica (2023)

    Fulltext@MSK | Save
  • Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma
    Journal Article

    Alarcon Tomas, A.; Fein, J. A.; Fried, S.; Flynn, J. R.; Devlin, S. M.; Fingrut, W. B.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with limited-stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era
    Research Letter

    Qualls, D.; Imber, B. S.; Okwali, M.; Hamlin, P. A.; Kumar, A.; Lahoud, O. B.; Matasar, M. J.; Noy, A.; Owens, C.; Zelenetz, A. D.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Targeting CD19 for diffuse large B cell lymphoma in the era of CARs: Other modes of transportation
    Review

    Sermer, D.; Elavalakanar, P.; Abramson, J. S.; Palomba, M. L.; Salles, G.; Arnason, J.
    Blood Reviews (2023)

    Fulltext@MSK | Save
  • Application of the lugano classification for initial evaluation, staging, and response assessment of hodgkin and non-hodgkin lymphoma: The PRoLoG consensus initiative (part 2-technical)
    Journal Article

    Ricard, F.; Barrington, S.; Korn, R.; Brueggenwerth, G.; Trotman, J.; Cheson, B.; Salles, G.; Schwartz, L.; Goldmacher, G.; Jarecha, R.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save